Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 12
Original Research
An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland, who have been prescribed Sativex® (THC:CBD, nabiximols) oromucosal spray
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 16,933 | Dovepress* | 14,115+ | 1,446 | 15,561 | |
| PubMed Central* | 2,818 | 569 | 3,387 | ||
| Totals | 16,933 | 2,015 | 18,948 | ||
| *Since 11 November 2016 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 0 | 0 | 0 | 3 | 5 |
View citations on PubMed Central and Google Scholar